GB9221212D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB9221212D0 GB9221212D0 GB929221212A GB9221212A GB9221212D0 GB 9221212 D0 GB9221212 D0 GB 9221212D0 GB 929221212 A GB929221212 A GB 929221212A GB 9221212 A GB9221212 A GB 9221212A GB 9221212 D0 GB9221212 D0 GB 9221212D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919121631A GB9121631D0 (en) | 1991-10-11 | 1991-10-11 | Pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9221212D0 true GB9221212D0 (en) | 1992-11-25 |
GB2260323A GB2260323A (en) | 1993-04-14 |
Family
ID=10702785
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919121631A Pending GB9121631D0 (en) | 1991-10-11 | 1991-10-11 | Pharmaceutical compositions |
GB9221212A Withdrawn GB2260323A (en) | 1991-10-11 | 1992-10-08 | 4-piperidinyl diphenylacetates |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB919121631A Pending GB9121631D0 (en) | 1991-10-11 | 1991-10-11 | Pharmaceutical compositions |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2673892A (en) |
GB (2) | GB9121631D0 (en) |
WO (1) | WO1993007122A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
CN1268938A (en) * | 1997-07-24 | 2000-10-04 | 三菱东京制药株式会社 | Aminocycloalkane compounds |
WO1999032443A1 (en) * | 1997-12-23 | 1999-07-01 | Alcon Laboratories, Inc. | Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB688354A (en) * | 1950-04-07 | 1953-03-04 | Nopco Chem Co | Improvements relating to compounds of the benzhydryl ether type |
JPS5427570A (en) * | 1977-07-30 | 1979-03-01 | Ota Pharma | Stereoisomer of 44acyloxyy11 alkyll11*1*33dioxolanee44 ylmethyl* pideridinium salt derivative |
JPS58208270A (en) * | 1982-05-28 | 1983-12-03 | Dainippon Pharmaceut Co Ltd | Alpha-cyclic aminophenylacetic esters, their acid addition salts and quaternary ammonium salts |
-
1991
- 1991-10-11 GB GB919121631A patent/GB9121631D0/en active Pending
-
1992
- 1992-10-08 AU AU26738/92A patent/AU2673892A/en not_active Abandoned
- 1992-10-08 WO PCT/GB1992/001829 patent/WO1993007122A1/en active Application Filing
- 1992-10-08 GB GB9221212A patent/GB2260323A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB9121631D0 (en) | 1991-11-27 |
GB2260323A (en) | 1993-04-14 |
AU2673892A (en) | 1993-05-03 |
WO1993007122A1 (en) | 1993-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9303143D0 (en) | Pharmaceutical compositions | |
ZA924719B (en) | Pharmaceutical composition | |
GB9210579D0 (en) | Pharmaceutical composition | |
GB9210974D0 (en) | Pharmaceutical composition | |
ZA922834B (en) | Pharmaceutical compositions | |
GB9203084D0 (en) | Pharmaceutical composition | |
GB9108080D0 (en) | Pharmaceutical composition | |
GB9200253D0 (en) | Pharmaceutical compositions | |
ZA925171B (en) | Pharmaceutical compositions | |
GB9120672D0 (en) | Pharmaceutical compositions | |
GB9121631D0 (en) | Pharmaceutical compositions | |
GB2252497B (en) | Pharmaceutical composition | |
GB9200414D0 (en) | Pharmaceutical compositions | |
GB9111477D0 (en) | Pharmaceutical composition | |
GB9119048D0 (en) | Pharmaceutical compositions | |
GB9113621D0 (en) | Pharmaceutical compositions | |
GB9123423D0 (en) | Pharmaceutical compositions | |
GB9121989D0 (en) | Pharmaceutical compositions | |
GB9121291D0 (en) | Pharmaceutical compositions | |
GB9100464D0 (en) | Pharmaceutical compositions | |
GB9107278D0 (en) | Pharmaceutical compositions | |
GB9118481D0 (en) | Pharmaceutical compositions | |
GB9108643D0 (en) | Pharmaceutical compositions | |
GB9118128D0 (en) | Pharmaceutical compositions | |
GB9113805D0 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |